CLINICAL_TRIALS
trial_result
· 2020-11-25
Clinical Trial Update: Individualized Treatment Strategy for Patients With Metastatic Non-clear Cell Renal Cell Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating an individualized treatment strategy for patients with metastatic non-clear cell renal cell carcinoma is ongoing, status currently unkn…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Herlev and Gentofte Hospital | Conditions: Metastatic Renal Cell Carcinoma, Kidney Neoplasm | Phase 2 | Status: UNKNOWN